Page 5 - Latest Updates on Trump tariffs

Trump's tariff rates could be restored to original levels by July: Bessent

Trump is seeking to restore his tariff wall using different authorities after the high court ruled that his use of emergency powers to impose those earlier duties was unconstitutional

US federal court hears new case against Trump's latest global tariffs

The centerpiece of US President Donald Trump's economic policy sweeping taxes on global imports is under legal assault again. The US Court of International Trade, a specialised court in New York, heard oral arguments on Friday in an attempt to overturn the temporary tariffs Trump turned to after the Supreme Court in February struck down his preferred choice even bigger, even more sweeping tariffs. In his first attempt to impose global tariffs, the president last year invoked the 1977 International Emergency Economic Powers Act (IEEPA), using the law to declare America's longstanding trade deficit a national emergency and to impose double-digit worldwide taxes on imports to combat it. He interpreted the law broadly to justify tariffs of whatever size he wanted, whenever he wanted to impose them, on whatever country he wanted to target. The Supreme Court struck those tariffs down on February 20, saying IEEPA did not authorise the use of tariffs to counter national emergencies. Bu

Coexistence as a strategy in the India-China reset

The latest bilateral engagement is a product of necessity amid the ongoing global turbulence, not trust

Patent wins vs tariff risks: Analysts pick top pharma stocks to bet on

Pharma stocks have, so far, outperformed the markets in 2026. However, as risk around Trump tariffs resurface, analysts suggest shifting to domestic-focused companies. Here's the investment strategy.

US pharma tariffs: CDMOs with innovator exposure likely to take a hit

Proposed US tariffs on patented drugs may pressure innovators to shift production locally, creating uncertainty for Indian CDMOs even as generics-led exports remain largely insulated

India likely to stay insulated from Trump's tariff shock on patented drugs

US tariffs on patented drugs may have limited immediate impact on India, but industry flags uncertainty as policy ties relief to pricing and manufacturing shifts

US tariffs on medicines decoded: Why Washington wants pharma production back

The US plans tariffs of up to 100 per cent on imported medicines to reduce foreign dependence and boost domestic manufacturing, a move that could reshape global pharmaceutical supply chains

Trump imposes 100% tariff on patented drug imports; generics spared

The US has announced a 100 per cent tariff on patented pharma imports from countries like India without reshoring deals, aiming to boost local production, while generics have been exempted for now

Trump to impose up to 100% tariffs on imported drugs with some exemptions

Duties for products made by certain larger companies will take effect in 120 days, while items from smaller manufacturers won't be hit for another 180 days, according to a White House statement

One year of Trump's Liberation Day tariffs: Who struck deals, who resisted

A year after it was announced, 'Liberation Day' has altered the mechanics of global trade as tariffs have succeeded in forcing negotiations in some cases and reshaping supply chains in others

Steel, aluminium stocks slide amid reports of Trump's 25% tariff plan

The Nifty Metal index fell over 3 per cent to hit an intraday low of 11,052.55, dragged by Hindustan Copper, Hindustan Zinc, APL Apollo Tubes, Tata Steel, SAIL, Adani Enterprises, and Jindal Steel

Trump admin set to roll out tiered tariffs on steel, aluminium imports

US plans 50% tariffs on many derivative goods, based on import value while others will face 25% duties, with some products taxed at even lower rates

WTO talks conclude, no consensus on extension of ecommerce duty moratorium

Talks on the e-commerce import duty ban reached a deadlock between Brazil and the US

Europe, Australia agree to free trade deal to boost ties, defy US

The conclusion of negotiations for the agreement was announced by Australian PM Anthony Albanese and Ursula von der Leyen, the EU's top executive

Trump's tariff playbook returns, this time with lawyering not legitimacy

The unusually rapid pace of these 76 inquiries raises concerns over due process, with expectations that responses may align closely with the Trump administration's preferred outcomes

PLI scheme shines for electronics, but questions linger over its future

The production-linked incentive scheme for large-scale electronics manufacturing, due to end on March 31, has propelled India as the second-largest smartphone maker in the world. What's its future?

India to sign US trade deal after Washington tariff reset: Commerce Secy

India will sign the trade pact with the US after Washington completes work on a new tariff architecture, Commerce Secretary Rajesh Agrawal said, adding there is no stand-off in the ongoing talks

Best of BS Opinion: Trump tariffs, euthanasia, rupee and farms

Today's Opinion page covers Trump's tariff strategy, the Supreme Court's passive euthanasia ruling, rupee depreciation amid West Asia tensions, farm diversification and a Syria war book review

Plan B for tariffs: USTR investigations are aimed at restricting imports

After the courts blocked earlier tariffs, the Trump administration turns to Section 301 probes to justify new duties-putting India and other major trading partners under scrutiny